Barinthus Biotherapeutics PLC (BRNS)
1.38
+0.06
(+4.55%)
USD |
NASDAQ |
Jun 25, 16:00
1.38
0.00 (0.00%)
After-Hours: 20:00
Barinthus Biotherapeutics Shareholders Equity (Quarterly): 171.83M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 171.83M |
| December 31, 2023 | 186.78M |
| September 30, 2023 | 195.40M |
| June 30, 2023 | 217.21M |
| March 31, 2023 | 233.30M |
| December 31, 2022 | 242.90M |
| September 30, 2022 | 243.84M |
| Date | Value |
|---|---|
| June 30, 2022 | 254.40M |
| March 31, 2022 | 252.74M |
| December 31, 2021 | 252.12M |
| September 30, 2021 | 241.98M |
| June 30, 2021 | 249.39M |
| March 31, 2021 | -53.11M |
| December 31, 2020 | -37.30M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-53.11M
Minimum
Mar 2021
254.40M
Maximum
Jun 2022
189.39M
Average
237.64M
Median
Shareholders Equity (Quarterly) Benchmarks
| Achilles Therapeutics PLC | 130.35M |
| TC BioPharm (Holdings) PLC | 1.364M |
| Virax Biolabs Group Ltd | 6.333M |
| Adaptimmune Therapeutics PLC | 24.38M |
| Biodexa Pharmaceuticals Plc | 5.959M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.48M |
| Total Liabilities (Quarterly) | 27.47M |